Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Pockets $1.6M SBIR Grant to Develop RNA-Amplification Technology

NEW YORK, Aug. 23 - Ambion today said it has won a $1.6 million Phase II SBIR grant from the US National Institutes of Health to continue developing its RNA-amplification technology.


Ambion, of Austin, Texas, said it hopes its technology will enhance the enzymatic processes to improve DNA microarray results and ultimately help researchers advance DNA arrays by integrating them onto both robotic and microfluidic platforms.


Click here for more information.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.